tiprankstipranks
Arbutus Biopharma Corporation (ABUS)
NASDAQ:ABUS
US Market
ABUS
Arbutus Biopharma
RESEARCH TOOLSreports
Want to see ABUS full AI Analyst Report?

Arbutus Biopharma (ABUS) Income Statement

1,272 Followers

Arbutus Biopharma Income Statement

Last quarter (Q4 2025), Arbutus Biopharma's total revenue was $1.05M, a decrease of -33.23% from the same quarter last year. In Q4, Arbutus Biopharma's net income was $-3.76M. See Arbutus Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 14.08M$ 6.17M$ 18.14M$ 39.02M$ 10.99M
Gross Profit
$ 13.72M$ 6.17M$ 18.14M$ 39.02M$ 10.99M
Operating Expenses
$ 40.77M$ 82.49M$ 96.24M$ 104.47M$ 84.51M
Depreciation and Amortization
$ 363.00K$ 1.38M$ 1.40M$ 1.43M$ 1.75M
EBITDA
$ -26.69M$ -68.40M$ -70.99M$ -61.86M$ -71.64M
Operating Income
$ -27.05M$ -76.32M$ -78.10M$ -65.46M$ -73.52M
Other Income/Expenses
$ -6.45M$ 6.40M$ 5.25M$ 444.00K$ -2.73M
Pretax Income
$ -33.50M$ -69.92M$ -72.85M$ -65.01M$ -76.25M
Net Income
$ -33.50M$ -69.92M$ -72.85M$ -69.46M$ -76.25M
Per Share Metrics
Basic EPS
$ -0.17$ -0.38$ -0.44$ -0.46$ -0.73
Diluted EPS
$ -0.17$ -0.38$ -0.44$ -0.46$ -0.73
Weighted Average Shares Outstanding
 191.60M 185.61M 165.96M 150.94M 106.24M
Weighted Average Shares Outstanding (Diluted)
 191.60M 185.61M 165.96M 150.94M 106.24M
Currency in USD

Arbutus Biopharma Earnings and Revenue History